Elevating PV from operations to strategic impact<\/h3>\n
Automation and safety-specific agentic AI promise significant innovation and productivity gains for biopharmas. To get there, many companies are working on simplifying processes and standardizing common data and workflows to speed automation of high-volume, manual tasks that may be prone to error or inconsistency. By reducing the operational burden and data reconciliation, PV teams gain more time to review and analyze data, investigate complex safety questions, and perform more in-depth assessments \u2014 enabling a greater focus on high-value, strategic work.<\/p>\n
Learn more<\/a>.<\/p>\n \n\u201cE2B data is easy to ingest because of the structure. But 60% of our data is not coming in that way,\u201d said Aniket Agarwal, the director of patient safety data operations and analytics at Sandoz. \u201cI think this is where AI can help structure that information so that you can use downstream automation to process it efficiently.\u201d\n<\/p><\/blockquote>\n For smaller biotechs, balancing outsourcing with data ownership and governance is a strategic imperative. With a fully outsourced model, \u201cI couldn’t get access to the data, I didn’t have access to the safety database,\u201d said Johanna Strandell, director of patient safety and QPPV at Camurus. With PV activities back in house, the biotech has kept costs steady despite increased cases and brought compliance levels to near 100%. The safety team can view reports and proactively address data issues. <\/p>\n Learn more<\/a>.<\/p>\n Small biopharmas often manage key safety documents like the pharmacovigilance system master file (PSMF), pharmacovigilance agreements (PVAs), and risk management plans in general-purpose, non-validated content management applications. While convenient in early stages, these tools are not designed for regulated PV processes \u2014 creating risks with no clear audit trails or validation documentation. Leveraging a scalable and extendable safety solution that manages PV processes and related content in a validated environment enables faster decision-making, stronger compliance, and continually supports the business as the needs evolve.<\/p>\n Learn more<\/a>.<\/p>\n Read the full report here<\/a>.<\/p>\n \u201cUsing Veeva Safety, we have reduced case processing time<\/a> by at least 30 minutes per case while maintaining compliance,\u201d says Johanna Strandell, director of patient safety, QPPV, Camurus.<\/p>\n<\/div>\nReducing operational costs with real-time data access and visibility<\/h3>\n
Improving collaboration, reducing risk<\/h3>\n
![\"\"](\"https:\/\/www.veeva.com\/wp-content\/uploads\/2025\/12\/camurus-video-1-resource-tile@2x.png\")
<\/p>\nCamurus Reduces Case Processing Time and Costs with In-House Safety<\/h2>\n
![\"\"](\"\/wp-content\/uploads\/2026\/01\/Safety-Revolution_All-Punchlist-Graphics_Ep-4-Veeva-Marius-Mortensen_Resource-Tile-340x220-1.png\")
<\/p>\nNew Episode: Building a Connected Safety Platform for the Future<\/h2>\n